These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8463904)

  • 1. Effect of treatment with glycine and L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency.
    Rinaldo P; Schmidt-Sommerfeld E; Posca AP; Heales SJ; Woolf DA; Leonard JV
    J Pediatr; 1993 Apr; 122(4):580-4. PubMed ID: 8463904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethylmalonic/adipic aciduria: effects of oral medium-chain triglycerides, carnitine, and glycine on urinary excretion of organic acids, acylcarnitines, and acylglycines.
    Rinaldo P; Welch RD; Previs SF; Schmidt-Sommerfeld E; Gargus JJ; O'Shea JJ; Zinn AB
    Pediatr Res; 1991 Sep; 30(3):216-21. PubMed ID: 1945558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.
    Roe CR; Millington DS; Maltby DA; Bohan TP; Kahler SG; Chalmers RA
    Pediatr Res; 1985 May; 19(5):459-66. PubMed ID: 4000772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
    Chalmers RA; Roe CR; Stacey TE; Hoppel CL
    Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acylcarnitine profiles during carnitine loading and fasting tests in a Japanese patient with medium-chain acyl-CoA dehydrogenase deficiency.
    Yokoi K; Ito T; Maeda Y; Nakajima Y; Ueta A; Nomura T; Koyama N; Kato I; Suzuki S; Kurono Y; Sugiyama N; Togari H
    Tohoku J Exp Med; 2007 Dec; 213(4):351-9. PubMed ID: 18075239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of supplementation with L-carnitine at a small dose on acylcarnitine profiles in serum and urine and the renal handling of acylcarnitines in a patient with multiple acyl-coenzyme A dehydrogenation defect.
    Yoshino M; Tokunaga Y; Watanabe Y; Yoshida I; Sakaguchi M; Hata I; Shigematsu Y; Kimura M; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(1):73-82. PubMed ID: 12828999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of urinary carnitine esters in a patient with medium-chain acyl-coenzyme A dehydrogenase deficiency: effect of metabolic state and L-carnitine therapy.
    Schmidt-Sommerfeld E; Penn D; Kerner J; Bieber LL; Rossi TM; Lebenthal E
    J Pediatr; 1989 Oct; 115(4):577-82. PubMed ID: 2795349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-carnitine and exercise tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: a pilot study.
    Lee PJ; Harrison EL; Jones MG; Jones S; Leonard JV; Chalmers RA
    J Inherit Metab Dis; 2005; 28(2):141-52. PubMed ID: 15877203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased fasting free fatty acids with L-carnitine in children with carnitine deficiency.
    Schwenk WF; Hale DE; Haymond MW
    Pediatr Res; 1988 May; 23(5):491-4. PubMed ID: 3290828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal handling of carnitine in secondary carnitine deficiency disorders.
    Stanley CA; Berry GT; Bennett MJ; Willi SM; Treem WR; Hale DE
    Pediatr Res; 1993 Jul; 34(1):89-97. PubMed ID: 8356025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of long-term oral L-carnitine administration on insulin sensitivity, glucose disposal, plasma concentrations of leptin and acylcarnitines, and urinary acylcarnitine excretion in warmblood horses.
    Kranenburg LC; Westermann CM; de Sain-van der Velden MG; de Graaf-Roelfsema E; Buyse J; Janssens GP; van den Broek J; van der Kolk JH
    Vet Q; 2014; 34(2):85-91. PubMed ID: 24893614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary acylcarnitines in a patient with neonatal multiple acyl-CoA dehydrogenation deficiency, quantified by a carboxylic acid analyzer with a reversed-phase column.
    Kidouchi K; Niwa T; Nohara D; Asai K; Sugiyama N; Morishita H; Kobayashi M; Wada Y
    Clin Chim Acta; 1988 Apr; 173(3):263-72. PubMed ID: 3383426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of urinary acylglycines and acylcarnitines as diagnostic markers of medium-chain acyl-CoA dehydrogenase deficiency.
    Rinaldo P; O'Shea JJ; Goodman SI; Miller LV; Fennessey PV; Whelan DT; Hill RE; Tanaka K
    J Inherit Metab Dis; 1989; 12 Suppl 2():325-8. PubMed ID: 2512435
    [No Abstract]   [Full Text] [Related]  

  • 14. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy.
    Westermann CM; Dorland L; Votion DM; de Sain-van der Velden MG; Wijnberg ID; Wanders RJ; Spliet WG; Testerink N; Berger R; Ruiter JP; van der Kolk JH
    Neuromuscul Disord; 2008 May; 18(5):355-64. PubMed ID: 18406615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
    Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
    Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation.
    Treem WR; Stanley CA; Goodman SI
    J Inherit Metab Dis; 1989; 12(2):112-9. PubMed ID: 2502671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects.
    Gregersen N; Wintzensen H; Christensen SK; Christensen MF; Brandt NJ; Rasmussen K
    Pediatr Res; 1982 Oct; 16(10):861-8. PubMed ID: 7145508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency.
    Huidekoper HH; Schneider J; Westphal T; Vaz FM; Duran M; Wijburg FA
    J Inherit Metab Dis; 2006 Oct; 29(5):631-6. PubMed ID: 16972171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases.
    Gregersen N; Kølvraa S; Rasmussen K; Mortensen PB; Divry P; David M; Hobolth N
    Clin Chim Acta; 1983 Aug; 132(2):181-91. PubMed ID: 6616873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.